EXAMINE THIS REPORT ON MBL77

Not all clients with CLL demand therapy. Inspite of all current improvements, the iwCLL however endorses watchful observation for clients with asymptomatic disease.86 This recommendation is predicated on at least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103